Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls
- PMID: 18213618
- DOI: 10.1002/humu.20668
Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls
Abstract
Mutation of LRRK2, encoding dardarin, is the most common known genetic cause of Parkinson's disease (PD). The large size of this gene and the relative ease with which the most common mutations can be screened means that although more than 50 LRRK2 screening papers have been published, few have analyzed the entire coding sequence. Furthermore, no comprehensive sequence-based analysis has been performed on control samples. Here, we present sequencing of all coding exons in a series of 275 PD cases and 275 neurologically normal controls and analysis of the LRRK2 locus for whole gene multiplications or deletions. We also present case-control SNP association results using 74 SNPs genotyped across LRRK2. We identified six novel disease-associated missense mutations, including two that altered the same residue of the protein. These data and analysis of previously reported disease-segregating mutations shows that the majority of disease-causing mutations lie in the C-terminal half of the protein.
Published 2008, Wiley-Liss, Inc.
Similar articles
-
Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.Neurodegener Dis. 2007;4(5):386-91. doi: 10.1159/000105160. Epub 2007 Jul 6. Neurodegener Dis. 2007. PMID: 17622782
-
LRRK2 gene in Parkinson disease: mutation analysis and case control association study.Neurology. 2005 Sep 13;65(5):696-700. doi: 10.1212/01.wnl.0000167552.79769.b3. Neurology. 2005. PMID: 16157901
-
LRRK2 gene variation and its contribution to Parkinson disease.Hum Mutat. 2009 Aug;30(8):1153-60. doi: 10.1002/humu.21038. Hum Mutat. 2009. PMID: 19472409
-
Mutations in LRRK2 as a cause of Parkinson's disease.Neurosignals. 2008;16(1):99-105. doi: 10.1159/000109764. Epub 2007 Dec 5. Neurosignals. 2008. PMID: 18097165 Review.
-
Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.Parkinsonism Relat Disord. 2012 Jul;18(6):722-30. doi: 10.1016/j.parkreldis.2012.04.013. Epub 2012 May 8. Parkinsonism Relat Disord. 2012. PMID: 22575234 Review.
Cited by
-
LRRK2 Phosphorylation, More Than an Epiphenomenon.Front Neurosci. 2020 Jun 16;14:527. doi: 10.3389/fnins.2020.00527. eCollection 2020. Front Neurosci. 2020. PMID: 32612495 Free PMC article. Review.
-
LRRK2 dephosphorylation increases its ubiquitination.Biochem J. 2015 Jul 1;469(1):107-20. doi: 10.1042/BJ20141305. Epub 2015 May 5. Biochem J. 2015. PMID: 25939886 Free PMC article.
-
Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson's Disease Progression.Neuromolecular Med. 2021 Jun;23(2):292-304. doi: 10.1007/s12017-020-08619-x. Epub 2020 Oct 4. Neuromolecular Med. 2021. PMID: 33015738
-
Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe.Hum Mutat. 2012 Jul;33(7):1087-98. doi: 10.1002/humu.22075. Epub 2012 Apr 4. Hum Mutat. 2012. PMID: 22415848 Free PMC article.
-
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.Biochem J. 2010 Sep 15;430(3):393-404. doi: 10.1042/BJ20100483. Biochem J. 2010. PMID: 20642453 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials